To assess the efficacy of a nutritional intervention with supplementation enriched in EPA to improve the tolerance to the antineoplastic treatment, using the variation in quality of life changes as the tolerability index.
To assess the influence of the nutritional status over the tolerance to the antineoplastic treatment.
To assess the effect of a nutritional supplement over the nutritional status of the patient with disseminated neoplastic illness.
18 Years and older (Adult, Senior)
EPA-05 EPA-05/ ACA-SPAI-05-05
November 10, 2006
June 20, 2013
Hospital Clinic of Barcelona Barcelona, Catalonia, Spain
† Study has passed its completion date and status has not been verified in more than two years.